Da: Fabbri LM [fabbri.leonardo@unimo.it] Inviato: mercoledì 9 febbraio 2005 13.23 A: 'Corbetta Lorenzo' Oggetto: I: Introduction Leonardo M. Fabbri, MD Professor of Respiratory Medicine Department of Respiratory Diseases University of Modena&ReggioEmilia Via del Pozzo 71,I-41100 MODENA Phone: +39-0594222198, -4198, -4227 Fax +39-0594224231 Mobile +39-3482945522 Email: fabbri.leonardo@unimo.it -----Messaggio originale----- Da: Fabbri LM [mailto:fabbri.leonardo@unimo.it] Inviato: lunedì 24 gennaio 2005 19.58 A: 'Rabe, K.F. (LONG)' Cc: Fabbri.Leonardo@Unimo.It (fabbri.leonardo@unimo.it) Oggetto: Introduction Issue related to Chapter 1 to be discussed in Rome Key Points 1. include preventable and treatable, nothing else (exacerbations, systemic, comorbidity should go to the text, under Natural history) 2. specify that the 4-stage classificatin is spirometric, and not for treatment that is symptmatic 3. no change 4. "often" should read "may", "identify" should read "may suggest and increased risk of developing COPD 5, 6 unchanged 7. symptomatology should read symptoms DEFINITION Page 6, right column, lines 6,5,4 from bottom, move "Airflow limitation at the end of the paragraph (page 7, left column, end of 1st paragraph) and emphisize the importance of lung function measurement NATURAL HISTORY Page 7, righ column, line 4: add exacerbations, systemic, comorbidities. CLASSIFICATION OF SEVERITY Figure 1.2: Spirometric classification of severity, remind NOT FOR TREATMENT Discuss concet of Post-bronchodilator Page 8, left column, para 3: change according to key point 4 VARIABLE COURSE Fig 1-3: do we need this figure Asthma vs COPD? Can be shortened Discuss response to traatmet REFERENCES Replace all Leonardo M. Fabbri, MD Professor of Respiratory Medicine Department of Respiratory Diseases University of Modena&ReggioEmilia Via del Pozzo 71,I-41100 MODENA Phone: +39-0594222198, -4198, -4227 Fax +39-0594224231 Mobile +39-3482945522 Email: fabbri.leonardo@unimo.it